dbt Labs vs Vercel: employee equity compared
Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between dbt Labs and Vercel.
dbt Labs
Creator of dbt (data build tool), the open-source SQL transformation layer used by 30,000+ data teams at Airbnb, JetBlue, and GitLab.
IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Sticky enterprise ARR; ISO/NSO options; IPO imminent when ARR > $1B
Vercel
Frontend cloud and deployment platform — the creator of Next.js (used by TikTok, Twitch, Hulu) and the host for 6M+ frontend deployments.
IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Sticky enterprise ARR; ISO/NSO options; IPO imminent when ARR > $1B
Key differences for employees
Equity structure
dbt Labs grants ISO/NSO with strike prices ranging from $14–$26 depending on your grant year. Vercel grants ISO/NSO with strike prices from $12–$20.
Secondary market premium
The secondary market is pricing dbt Labs at a +2% premium over its last primary round ($4.2B → $4.3B). Vercel trades at +2% over its last round ($3.3B → $3.3B). A higher secondary premium signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.
Revenue and growth
dbt Labs runs at $0.1B ARR, growing +50% YoY (fast). Vercel runs at $0.1B ARR, growing +80% YoY (fast). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.
Liquidity timeline
dbt Labs: IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Vercel: IPO possible 2027–2029 once ARR milestones are hit. Strategic M&A also plausible in consolidating sector.
Calculate your specific grant
Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value at both companies using 4 independent methods.